Diagnostic Kits/Give an overall picture of the Kits' sector: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
Line 10: Line 10:
==Is this field replicating models from other fields?==
==Is this field replicating models from other fields?==
==How many companies?==
==How many companies?==
* Diagnostic Kit Manufacturers:
* Diagnostic laboratories:
** Hospital Labs:
** References labs:
** CLIA labs:
* CLIA labs offering ASR-based diagnostics:
=== 2002 US Market share ===
[[Image:The Value of Diagnostics Innovation Adoption and Diffusion Into Health - 2005 Goodman.png]] "In 2002, nine companies accounted for 78% of the US diagnostics market" - [[Diagnostic_Kits/The Value of Diagnostics: Innovation, Adoption and Diffusion Into Health Care|The Value of Diagnostics pg. 53]], referencing ''Quirk WR. The in-vitro diagnostics industry: overview and emerging opportunities. Toronto, Canada: RBC Capital Markets, 2003.''
* Roche: 22%
* Abbott Labs: 11%
* J&J: 9%
* Gen-Probe: 8%
* Beckman C: 6%
* Becton D: 6%
* Dade Behring: 6%
* Bayer: 5%
* BioMerieux: 5%
* other: 22%
==How much money do they make or how much money do they “move” in the American economy?==
==How much money do they make or how much money do they “move” in the American economy?==
==How important is research from universities in this specific field?==
==How important is research from universities in this specific field?==

Revision as of 13:40, 24 September 2009

Many of these questions can be answered from data in the The Value of Diagnostics report (caution: sponsored by AdvaMed), starting with the Profile of the Diagnostics Industry section.

How was this field born and how is it evolving?

The Value of Diagnostics Innovation Adoption and Diffusion Into Health - 2005 Goodman p20.png

What are the main business models?

What are the innovation dynamics in this field? (inputs/outputs, timing of innovation/ disruptive or incremental innovation?)

How does knowledge flow in this field?

Is this field replicating models from other fields?

How many companies?

  • Diagnostic Kit Manufacturers:
  • Diagnostic laboratories:
    • Hospital Labs:
    • References labs:
    • CLIA labs:
  • CLIA labs offering ASR-based diagnostics:

2002 US Market share

The Value of Diagnostics Innovation Adoption and Diffusion Into Health - 2005 Goodman.png "In 2002, nine companies accounted for 78% of the US diagnostics market" - The Value of Diagnostics pg. 53, referencing Quirk WR. The in-vitro diagnostics industry: overview and emerging opportunities. Toronto, Canada: RBC Capital Markets, 2003.

  • Roche: 22%
  • Abbott Labs: 11%
  • J&J: 9%
  • Gen-Probe: 8%
  • Beckman C: 6%
  • Becton D: 6%
  • Dade Behring: 6%
  • Bayer: 5%
  • BioMerieux: 5%
  • other: 22%

How much money do they make or how much money do they “move” in the American economy?

How important is research from universities in this specific field?

How important is public funding in this field?

How important is private funding / venture capital in this field?

Are there any specific public policies (from agencies, federal or state policies) that give incentives for openness or enclosure?

What is the cost structure of the field?

Who are the producers, the buyers, and the users?

What is the structure of power from the production side and what is the structure of power in the demand side? e.g. Who has the power to control production and demand? How is the control distributed?

Navigation

Main Page Diagnostic_Kits

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Diagnostic_Kits/Give_an_overall_picture_of_the_Kits%27_sector&oldid=4264"